✦ LIBER ✦

PCN16 A COMPARISON OF THE COSTS OF GEMCITABINE/CISPLATIN AND GEMCITABINE/CARBOPLATIN COMBINATION REGIMENS IN THE TREATMENT OF ADVANCED NSCLC IN THE UK AND FRANCE

✍ Scribed by DP Tilden; M Aristides; G Stynes; A Kielhorn; S Bhalla

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-minimisation analysis comparing gem

✍ Novello, S.; Kielhorn, A.; Stynes, G.; Selvaggi, G.; De Marinis, F.; Maestri, A. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 177 KB

Combination of docetaxel and gemcitabine

✍ Jensen, N.V.; Hansen, O.; Rose, C. 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 165 KB

16 Transfusion costs associated with use

✍ Abdul Razak, A.R.; Chhabra, R.; Nielson, A.; Dobson, J.; McMenemin, R.; Gardiner 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 44 KB

CLC030 POSTER Eficacy and safety of comb

✍ Heras, P.; Hatzopoulos, A.; Kritikos, K.; Georgopoulou, A. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Comparative study of gemcitabine plus ci

✍ Shu, Yongqian ;Liu, Lianke ;Liu, Lingxiang ;Huang, Puwen ;Lu, Kaihua ;Yin, Yongm 📂 Article 📅 2004 🏛 Springer-Verlag ⚖ 409 KB

Pharmacology of the paclitaxel–cisplatin

✍ J. R. Kroep; E. F. Smit; G. Giaccone; K. Van der Born; J. H. Beijnen; C. J. Van 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 248 KB